This is a discussion on Relievant Medsystems Receives FDA Approval To Begin Pivotal Study To Evaluate The Intracept System For Minimally Invasive Treatment Of Low Back Pain within the Education, Research and Spine Publications forums, part of the General Spine Discussion Forums category; Relievant Medsystems, Inc. announced the company has received Food and Drug Administration approval of an Investigational Device Exemption (IDE) to ...
Relievant Medsystems Receives FDA Approval To Begin Pivotal Study To Evaluate The Intracept System For Minimally Invasive Treatment Of Low Back Pain Relievant Medsystems, Inc. announced the company has received Food and Drug Administration approval of an Investigational Device Exemption (IDE) to begin their SMART pivotal trial to evaluate the safety and effectiveness of the Intracept® System for treatment of chronic low back pain.....
Relievant Medsystems Receives FDA Approval To Begin Pivotal Study To Evaluate The Intracept System For Minimally Invasive Treatment Of Low Back Pain (click here for the full article at Medical News Today)
Justin Averna
Founder & President, Spine Patient Society™
www.SpinePatientSociety.org
A 501(c)(3) Tax-Exempt Nonprofit & Charitable Organization
I'm here to help.
- 1994: Football Injury, Severe Hyperextension
- 1997: Snow Skiing Injury
- 3/7/1997: Laminotomy L4/L5
- 1999 & 2003: Motor Vehicle Accidents (not at fault both times) --> Grade V Annular Tears L4/L5 & L5/L6
- 11/15/2003: 2-Level ProDisc® L4/L5 & L5/L6*, *lumbosacral transitional vertebra --> Dr. Rudolf Bertagnoli
- 4/2008: 4.5 years pain-free before "new" leg pain
- 5/14/2009: Dynamic Stabilization System L4/L5, Dr. Rudolf Bertagnoli
Questions? Suggestions? Need help with registering, creating a signature, etc.?
justin (at) spinepatientsociety.org
Disclosure: I have no financial relationships with any surgeons, spine clinics, device manufacturers, pharmaceutical companies, hospitals, etc. -- the SPS Board of Directors serve without compensation.
Posting Permissions
LinkBack URL
About LinkBacks
Reply With Quote
Bookmarks